Senior finance executive and investor focused on emerging markets, Steven JE Manders brings operational and capital-markets experience spanning corporate finance, strategic advisory and private investments. Known for structuring cross-border transactions and portfolio optimization, he has worked with corporates and PE firms on M&A, capital raising and turnaround assignments. Market-oriented analyst with emphasis on governance, cash-flow improvement and value realization; active in board advisory and deal sourcing across fintech, energy and industrial sectors.
Senior finance executive and investor focused on emerging markets, Steven JE Manders brings operational and capital-markets experience spanning corporate finance, strategic advisory and private investments. Known for structuring cross-border transactions and portfolio optimization, he has worked with corporates and PE firms on M&A, capital raising and turnaround assignments. Market-oriented analyst with emphasis on governance, cash-flow improvement and value realization; active in board advisory and deal sourcing across fintech, energy and industrial sectors.
Seasoned emerging-markets investor who prioritizes cash-flow-driven value and disciplined capital allocation. Focuses on control and minority investments that enable operational turnaround, governance upgrades and cross-border structuring to unlock value. Balances private equity-style active ownership with strategic advisory, favoring fintech, energy and industrials where structural growth and margin improvement are visible. Uses rigorous underwriting, scenario-based stress tests and staged capital release to manage downside while targeting multi-year capital appreciation through portfolio optimization and exit planning.
Seasoned emerging-markets investor who prioritizes cash-flow-driven value and disciplined capital allocation. Focuses on control and minority investments that enable operational turnaround, governance upgrades and cross-border structuring to unlock value. Balances private equity-style active ownership with strategic advisory, favoring fintech, energy and industrials where structural growth and margin improvement are visible. Uses rigorous underwriting, scenario-based stress tests and staged capital release to manage downside while targeting multi-year capital appreciation through portfolio optimization and exit planning.
| Trades 2060 | Longs Won 1548/2060 75% | Profit Factor 22.12 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $1.71M |
| Average Win $136,836.87 | Best Trade (Mar 30) $72.22M | Sharpe Ratio -10.03 |
| Average Loss -$18,701.44 | Worst Trade (Sep 29) -$592,661.96 | Z-Score 10.5 (100%) |
| Commissions $0 | Avg. Trade Length 1y 3w 5d | Expectancy $98,178.81 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.1% | 1.32% | 12.97% |
| Consecutive Losing Trades | 15,625 | 14,063 | 12,500 | 10,938 | 9,375 | 7,813 | 6,250 | 4,688 | 3,125 | 1,563 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 45,360 | $10.02M | $15.65M | - | $5.63M | 56.19% | +0.901% |
ABBV AbbVie Inc. | 1,180 | $226,973.45 | $336,831 | - | $109,857.55 | 48.4% | +0.723% |
ABT Abbott Laboratories | 5,935 | $737,374.12 | $623,353.05 | - | -$114,021.07 | -15.46% | +0.334% |
ADI Analog Devices, Inc. | 12,810 | $2.8M | $5.2M | - | $2.4M | 85.85% | +0.587% |
AEP American Electric Power Company, Inc. | 5,229 | $536,268.26 | $660,413.81 | - | $124,145.55 | 23.15% | +1.616% |
AFL Aflac Inc. | 1,767 | $196,473.39 | $209,230.47 | - | $12,757.08 | 6.49% | +0.305% |
AGG iShares Core U.S. Aggregate Bond ETF | 6,618 | $647,564.11 | $632,184.45 | - | -$15,379.66 | -2.38% | +0.121% |
AMAT Applied Materials, Inc. | 400 | $289,200 | $169,020 | - | -$120,180 | -41.56% | -1.735% |
AMD Advanced Micro Devices, Inc. | 364 | $211,451 | $198,562 | - | -$12,889 | -6.1% | -2.976% |
AMGN Amgen Inc. | 5,715 | $1.65M | $2.49M | - | $844,174.55 | 51.19% | +0.514% |
AMZN Amazon.com Inc | 7,234 | $1.64M | $1.83M | - | $189,435.59 | 11.52% | -0.524% |
ARCC Ares Capital Corporation | 56,152 | $1.12M | $1.06M | - | -$52,729.56 | -4.72% | +0.132% |
ASML ASML Holding N.V. New York Registry Shares | 1,102 | $845,548.31 | $1.85M | - | $1.01M | 118.92% | +1.344% |
AVGO Broadcom Inc. | 19,317 | $4.12M | $6.53M | - | $2.41M | 58.55% | -1.777% |
AZN AstraZeneca PLC American Depositary Shares | 3,070 | $603,144.08 | $511,983.9 | - | -$91,160.18 | -15.11% | +0.054% |
BAC Bank of America Corporation | 5,054 | $225,302.21 | $264,071.5 | - | $38,769.29 | 17.21% | +1.064% |
BAR GraniteShares Gold Trust | 34,540 | $961,780.56 | $1.42M | - | $463,167.14 | 48.16% | +0.402% |
BCS Barclays PLC Sponsored ADR | 34,269 | $721,816.12 | $793,841.38 | - | $72,025.26 | 9.98% | +1.556% |
BLK BlackRock, Inc. | 3,706 | $3.82M | $4.22M | - | $406,047.85 | 10.64% | +1.635% |
BNY BlackRock New York Municipal Income Trust | 1,809 | $197,997.8 | $260,061.82 | - | $62,064.02 | 31.35% | +1.175% |